Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

19.7K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
19.7K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

9.2K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.8K
1.8K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

6.4K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.4K
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

4.3K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
4.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

p16<sup>High</sup> immune cells control disease tolerance as a defense and health span-extending strategy.

Immunity·2026
Same author

Lack of MDA5 delays hematopoietic aging by modulating inflammaging and proteostasis in mice.

Nature communications·2026
Same author

TE-PARPi as a precision weapon against hematologic cancers.

Blood·2025
Same author

cGAS-STING are responsible for premature aging of telomerase-deficient zebrafish.

The EMBO journal·2025
Same author

Targeting heterochromatin eliminates chronic myelomonocytic leukemia malignant stem cells through reactivation of retroelements and immune pathways.

Communications biology·2024
Same author

PD-L1 blockade immunotherapy rewires cancer-induced emergency myelopoiesis.

Frontiers in immunology·2024

Related Experiment Video

Updated: Apr 12, 2026

Efficient Purification and LC-MS/MS-based Assay Development for Ten-Eleven Translocation-2 5-Methylcytosine Dioxygenase
10:33

Efficient Purification and LC-MS/MS-based Assay Development for Ten-Eleven Translocation-2 5-Methylcytosine Dioxygenase

Published on: October 15, 2018

8.7K

Fish provide ID(H)eas on targeting leukemia.

Eirini Trompouki1

  • 1MAX PLANCK INSTITUTE OF IMMUNOBIOLOGY AND EPIGENETICS.

Blood
|May 9, 2015
PubMed
Summary

Researchers explored the function of isocitrate dehydrogenase 1 (IDH1) and IDH2 in blood cell development. They found that IDH1 mutations common in human leukemia can cause similar effects in zebrafish, highlighting a conserved mechanism.

Area of Science:

  • Hematology
  • Molecular Biology
  • Developmental Biology

Background:

  • Isocitrate dehydrogenase 1 (IDH1) and IDH2 are key enzymes in cellular metabolism.
  • Mutations in IDH1 are frequently observed in various human cancers, including acute myeloid leukemia (AML).
  • The precise role of IDH1 and IDH2 in normal blood cell formation (hematopoiesis) is not fully understood.

Purpose of the Study:

  • To investigate the function of IDH1 and IDH2 during embryonic blood development.
  • To determine if human IDH1 mutations identified in leukemia retain their leukemogenic potential in a vertebrate model system.
  • To explore the conserved mechanisms underlying IDH-driven leukemogenesis.

Main Methods:

  • Utilized zebrafish (Danio rerio) as a model organism for studying hematopoiesis.

More Related Videos

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
10:49

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on: September 18, 2013

18.8K
Simplified Intrafemoral Injections Using Live Mice Allow for Continuous Bone Marrow Analysis
06:28

Simplified Intrafemoral Injections Using Live Mice Allow for Continuous Bone Marrow Analysis

Published on: November 10, 2023

4.8K

Related Experiment Videos

Last Updated: Apr 12, 2026

Efficient Purification and LC-MS/MS-based Assay Development for Ten-Eleven Translocation-2 5-Methylcytosine Dioxygenase
10:33

Efficient Purification and LC-MS/MS-based Assay Development for Ten-Eleven Translocation-2 5-Methylcytosine Dioxygenase

Published on: October 15, 2018

8.7K
Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
10:49

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on: September 18, 2013

18.8K
Simplified Intrafemoral Injections Using Live Mice Allow for Continuous Bone Marrow Analysis
06:28

Simplified Intrafemoral Injections Using Live Mice Allow for Continuous Bone Marrow Analysis

Published on: November 10, 2023

4.8K
  • Generated zebrafish models expressing wild-type and mutant forms of IDH1 and IDH2.
  • Employed molecular and cellular biology techniques to analyze hematopoietic development and gene expression in zebrafish embryos.
  • Assessed the impact of IDH1 mutations on hematopoietic stem cell populations and differentiation.

    • Main Results:

    • Demonstrated that IDH1 and IDH2 play critical roles in regulating hematopoietic stem cell proliferation and differentiation during zebrafish development.
    • Showed that introducing human IDH1 mutations into zebrafish recapitulates key features of human AML, including altered blood cell production and increased stem cell populations.
    • Confirmed the conserved oncogenic function of IDH1 mutations across species, from humans to zebrafish.

    Conclusions:

    • IDH1 and IDH2 are essential regulators of normal developmental hematopoiesis.
    • Human IDH1 mutations possess conserved leukemogenic potential, driving aberrant hematopoiesis in a zebrafish model.
    • Zebrafish serve as a valuable model for studying the mechanisms of IDH-mutated leukemias and for potential therapeutic target identification.